HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Differential miRNA expressions in peripheral blood mononuclear cells for diagnosis of lung cancer.

Abstract
Tremendous efforts have been made to develop cancer biomarkers by detecting circulating extracellular miRNAs directly released from tumors. Yet, none of the cell-free biomarkers has been accepted to be used for early detection of non-small cell lung cancer (NSCLC). Peripheral blood mononucleated cells (PBMCs) act as the first line of defense against malignancy in immune system, their dysfunction may occur as an early event in cancer immunogenicity or immune evasion. We proposed to investigate whether analysis of miRNA expressions of PBMCs has diagnostic value for NSCLC. We first used a microarray to analyze PBMCs of 16 stage I NSCLC patients and 16 cancer-free smokers, and identified seven PBMC miRNAs with a significantly altered expression level in NSCLC patients. In a training set of 84 NSCLC patients and 69 cancer-free smokers, a panel of two miRNAs (miRs-19b-3p and -29b-3p) were developed from the seven PBMC miRNAs, producing 72.62% sensitivity and 82.61% specificity in identifying NSCLC. Furthermore, the miRNAs could identify squamous cell lung carcinoma (SCC), a major type of NSCLC, with 80.00% sensitivity and 89.86% specificity. The expression levels of the miRNAs were independent of disease stage. In a testing set of 56 NSCLC patients and 46 controls, the performance of the biomarkers was reproducibly confirmed. The study presents the first in-depth analysis of PBMC miRNA profile of NSCLC patients. The assessment of PBMC miRNAs may provide a new diagnostic approach for the early detection of NSCLC.
AuthorsJie Ma, Yanli Lin, Min Zhan, Dean L Mann, Sanford A Stass, Feng Jiang
JournalLaboratory investigation; a journal of technical methods and pathology (Lab Invest) Vol. 95 Issue 10 Pg. 1197-206 (Oct 2015) ISSN: 1530-0307 [Electronic] United States
PMID26146958 (Publication Type: Journal Article, Multicenter Study, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S.)
Chemical References
  • Biomarkers
  • MIRN19 microRNA, human
  • MIRN29a microRNA, human
  • MicroRNAs
Topics
  • Aged
  • Biomarkers (metabolism)
  • Carcinoma, Non-Small-Cell Lung (blood, diagnosis, metabolism, pathology)
  • Carcinoma, Squamous Cell (blood, diagnosis, metabolism)
  • Case-Control Studies
  • Cohort Studies
  • Early Detection of Cancer
  • Female
  • Follow-Up Studies
  • Gene Expression Regulation, Neoplastic
  • Humans
  • Leukocytes, Mononuclear (metabolism)
  • Lung (pathology)
  • Lung Neoplasms (blood, diagnosis, metabolism, pathology)
  • Male
  • Maryland
  • MicroRNAs (metabolism)
  • Middle Aged
  • Neoplasm Staging
  • Oligonucleotide Array Sequence Analysis
  • Sensitivity and Specificity

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: